Different Modalities for the Evaluation of Patients With Peri-menopausal Bleeding

What this trial studies

The study aims to compare between 3D ultrasonography and hysteroscopy for the evaluation of cases with Peri-menopausal bleeding

Conditions in scope

• Perimenopausal Bleeding

Interventions

• three dimensional ultrasonography (Diagnostic Test) — all recruited patients will be subjected to three dimensional ultrasonography to diagnose the cause of perimenopausal bleeding
• Hysteroscopy (Diagnostic Test) — diagnostic hysteroscopy will be performed to diagnose the cause of perimenopausal bleeding

Who can join

Women only · Ages 40 Years to 55 Years

Inclusion criteria

• Any pattern of abnormal uterine bleeding as menorrhagia or metrorrhagia for more than 3 months at age between 40 and 55 years , and no ovarian lesion or local cause of bleeding as vaginal or cervical ulcer

Exclusion criteria

• Women with postmenopausal bleeding.
• Systemic causes of perimenopausal bleeding DM Hypertension or chronic liver disease.
• Women on hormonal therapy or using any contraception as IUD.
• Women have contraindication for hysteroscopy as cervical stenosis or pregnancy.

Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.

Where it’s happening

Status & timeline

• Overall status: Recruiting
• Study type: Interventional
• Phase: N/A
• Start date: 2025-12-01
• Primary completion: 2026-08-31
• Last update posted: 2025-12-30
• First posted: 2025-12-30

Sponsor & contact

Lead sponsor: Sohag University (Other)

For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.

Outcome measures

Primary outcomes

• The sensitivity and specificity of the 3D ultrasonography for the diagnosis of the causes of peri-menopausal bleeding as compared to hysteroscopy (9 months)

Related ClearedRx care

If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.